search
Back to results

Bioresorbable Intramedullary Nailing of Forearm Fractures (BRINFF)

Primary Purpose

Forearm Fracture

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
MRI Scan
Sponsored by
Thomas Klestil
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Forearm Fracture

Eligibility Criteria

3 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diaphyseal forearm fractures (radius or ulna or both)
  • Patients from 3 years to under 13 years, but the age limits depend on the biological development of the child and in addition

Exclusion Criteria:

  • multifragmentary fractures, metaphyseal and epiphyseal fractures
  • Situations where internal fixation is otherwise contraindicated, e.g., active or potential infection, or where a patient's cooperation cannot be guaranteed.

Sites / Locations

  • Landesklinikum MoedlingRecruiting
  • Herlev and Gentofte University Hospital Department of Orthopedic Surgery
  • Hvidovre Hospital
  • Lille University Center, Jeanne de Flandre Hospital
  • University Medical Center Schleswig-Holstein, Campus Lübeck Department of Pediatric Surgery
  • Péterfy Hospital, National Trauma Center, Department of Pediatric Trauma SurgeryRecruiting
  • Pécs University Hospital, Department of Pediatrics
  • Hospital Pediátrico - CHUC, EPE
  • Centre Hospitalier Universitaire Vaudois

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

MRI scan 1st and 2nd year

Arm Description

Additionally to routinely follow up, there will be an MRI scan of enrolled patients after one and two years in some of the study sites

Outcomes

Primary Outcome Measures

Refracture rate
Assessment of refracture rate

Secondary Outcome Measures

Absorption of implant
MRI scans are performed to evaluate soft tissue reaction and biodegradability
Bony union
Bony union depending on fracture type and immobilization time, return to sport
Monteggia lesion and equivalent
Safety and performance of operative technique in Monteggia´s lesion
Cost effectiveness
HTA assessment for different health care systems in Europe

Full Information

First Posted
April 13, 2021
Last Updated
April 13, 2021
Sponsor
Thomas Klestil
Collaborators
Bioretec Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT04846543
Brief Title
Bioresorbable Intramedullary Nailing of Forearm Fractures
Acronym
BRINFF
Official Title
PMCF Study - Verification of Activa IM-Nail™ Safety and Clinical Performance
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2021 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
September 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Thomas Klestil
Collaborators
Bioretec Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The Activa IM-Nail™ is used in the fixation of forearm fractures with cast to achieve a level of reduction and stabilisation that is appropriate to the age of the child. The post-market clinical follow-up study will be performed to identify the residual risk related to re-fracture and to determine its impact to the risk/benefit ratio of Activa IM-Nail™.
Detailed Description
Residual risk related to re-fracture rate will be addressed by this PMCF study. The research question is, if the re-fracture risk with Activa IM-nail is in line with the other treatment methods, namely ESIN. Primary objective: will be to assess clinical outcome by determining re-fracture rate of all treated patients, difference of re-fracture rate depending on the fracture type determined by X-ray (e.g. greenstick vs. non-greenstick fracture), subject's age, BMI, surgical technique, immobilization time and bony union formation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Forearm Fracture

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
220 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MRI scan 1st and 2nd year
Arm Type
Other
Arm Description
Additionally to routinely follow up, there will be an MRI scan of enrolled patients after one and two years in some of the study sites
Intervention Type
Other
Intervention Name(s)
MRI Scan
Intervention Description
MRI scan
Primary Outcome Measure Information:
Title
Refracture rate
Description
Assessment of refracture rate
Time Frame
First year after operation
Secondary Outcome Measure Information:
Title
Absorption of implant
Description
MRI scans are performed to evaluate soft tissue reaction and biodegradability
Time Frame
One and two years after operation
Title
Bony union
Description
Bony union depending on fracture type and immobilization time, return to sport
Time Frame
One year after operation
Title
Monteggia lesion and equivalent
Description
Safety and performance of operative technique in Monteggia´s lesion
Time Frame
2 years after operation
Title
Cost effectiveness
Description
HTA assessment for different health care systems in Europe
Time Frame
1 year after operation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diaphyseal forearm fractures (radius or ulna or both) Patients from 3 years to under 13 years, but the age limits depend on the biological development of the child and in addition Exclusion Criteria: multifragmentary fractures, metaphyseal and epiphyseal fractures Situations where internal fixation is otherwise contraindicated, e.g., active or potential infection, or where a patient's cooperation cannot be guaranteed.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christoph Roeder, MD
Phone
+4322529004
Ext
27166
Email
christoph.roeder@moedling.lknoe.at
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas Klestil, MD
Phone
+4322529004
Ext
13201
Email
thomas.klestil@moedling.lknoe.at
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph Roeder, MD
Organizational Affiliation
Landesklinikum Baden/Moedling
Official's Role
Principal Investigator
Facility Information:
Facility Name
Landesklinikum Moedling
City
Mödling
State/Province
Lower Austria
ZIP/Postal Code
2340
Country
Austria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christoph Roeder, MD
Phone
+4322529004
Ext
27166
Email
christoph.roeder@moedling.lknoe.at
First Name & Middle Initial & Last Name & Degree
Thomas Klestil, MD
Phone
+4322529004
Ext
13201
Email
thomas.klestil@moedling.lknoe.at
Facility Name
Herlev and Gentofte University Hospital Department of Orthopedic Surgery
City
Herlev
ZIP/Postal Code
2730
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Morten Andersen
Phone
+ 45 38 68 14 79
Email
morten.jon.andersen@regionh.dk
Facility Name
Hvidovre Hospital
City
Hvidovre
ZIP/Postal Code
2650
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Louise Klingenberg
Phone
0045 40884943
Email
louise.klingenberg.03@regionh.dk
Facility Name
Lille University Center, Jeanne de Flandre Hospital
City
Lille
ZIP/Postal Code
59000
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Federico Canavese, Prof.
Phone
+33 3 20 44 68 67
Email
federico.canavese@chru-lille.fr
Facility Name
University Medical Center Schleswig-Holstein, Campus Lübeck Department of Pediatric Surgery
City
Lübeck
State/Province
Schleswig-Holstein
ZIP/Postal Code
23538
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ludger Tüshaus
Phone
+49 451 500 42611
Email
ludger.tueshaus@uksh.de
Facility Name
Péterfy Hospital, National Trauma Center, Department of Pediatric Trauma Surgery
City
Budapest
Country
Hungary
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marcell Varga
Phone
0036 79 932 30 27
Email
drvmarcell@gmail.com
Facility Name
Pécs University Hospital, Department of Pediatrics
City
Pécs
ZIP/Postal Code
7623
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gergo Jozsa
Phone
+3672/535-900
Email
dr.jozsa.gergo@gmail.com
Facility Name
Hospital Pediátrico - CHUC, EPE
City
Coimbra
ZIP/Postal Code
3000-602
Country
Portugal
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cristina Alves
Phone
+351239480355
Email
6443@chuc.min-saude.pt
Facility Name
Centre Hospitalier Universitaire Vaudois
City
Lausanne
ZIP/Postal Code
1010
Country
Switzerland
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicolas Lutz

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30292588
Citation
Korhonen L, Perhomaa M, Kyro A, Pokka T, Serlo W, Merikanto J, Sinikumpu JJ. Intramedullary nailing of forearm shaft fractures by biodegradable compared with titanium nails: Results of a prospective randomized trial in children with at least two years of follow-up. Biomaterials. 2018 Dec;185:383-392. doi: 10.1016/j.biomaterials.2018.09.011. Epub 2018 Sep 11.
Results Reference
background

Learn more about this trial

Bioresorbable Intramedullary Nailing of Forearm Fractures

We'll reach out to this number within 24 hrs